Navigation Links
Triple Revenue Growth Rate for Transplant Molecular Testing, According to Report
Date:5/3/2017

ROCKVILLE, Md., May 3, 2017 /PRNewswire/ -- Kalorama Information notes that transplant diagnostics is seeing revenue growth of nine percent next year and this is projected to continue to 2021. Successful solid organ and hematopoietic stem cell (HSCT) or bone marrow transplants require histocompatibility between the recipient and donor. Molecular testing technologies are well-suited for this task. This according to a new report from healthcare-only market research publisher Kalorama Information. The various PCR-based methodologies, Sanger sequencing and NGS used to type HLA alleles in low to high resolution in order to match donors and recipients for solid organ and hematopoietic stem cell (HSCT) or bone marrow transplants; post-transplant monitoring including for transplant rejection is an ancillary testing area. The finding was made in the firm's report Transplant Matching Molecular Diagnostics.

"Molecular is not ubiquitous, as some forecasters – including us- may have thought a decade ago," said Bruce Carlson, Publisher of Kalorama Information. "It performs well in areas where it is set apart from other technologies. HLA is a value-add area for molecular, and you see that in the growth rate."

The report said the global market for molecular transplant diagnostics is estimated at over three hundred million at an average annual rate of growth of 9%. Over allogenic 9,000 HSCTs and approximately 30,000 solid organ transplants are performed in the United States each year. The large size of the U.S. market is sustained by demand for high resolution molecular HLA typing, including sequencing-based methods. More than 30,000 solid organ transplants and around 18,000 HSCTs are performed each year in Europe. Transplant volumes continue to grow at a faster pace in Europe than in the United States as Eastern European countries and other less mature markets perform more solid organ transplants and HSCTs. This is driving sales of test products. 

The United States is the largest market for leading molecular transplant diagnostics companies Thermo Fisher Scientific, CareDx (Olerup brand), and Immucor (LIFECODES brand).

Kalorama's report, Transplant Matching Molecular Diagnostics Market provides:  

  • Global Market Forecast to 2021
  • Global Molecular Transplant Procedure Volumes, 2016 to 2021
  • Global Market Share by Vendor

The report can be found at:  https://www.kaloramainformation.com/Transplant-Matching-Molecular- 10819543/

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.  

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website.  

Please link any media or news references to our reports or data to http://www.kaloramainformation.com/.

Press Contact:
Bruce Carlson
212 807 2262
bcarlson@marketresearch.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/triple-revenue-growth-rate-for-transplant-molecular-testing-according-to-report-300450452.html


'/>"/>
SOURCE Kalorama Information
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. CASI Pharmaceuticals Reports On Enrollment Status Of ENMD-2076 Phase 2 Study In Triple-Negative Breast Cancer
2. Landmark Study Published Today in The Lancet Shows Clear Myeloma Survival Benefit with Triple Drug Combination
3. Theravance Biopharma Highlights Initiation of Phase 3 Study of the Closed Triple in Patients with Asthma by GlaxoSmithKline and Innoviva
4. Theravance Biopharma Highlights Filing of U.S. New Drug Application for the Closed Triple in COPD by GlaxoSmithKline and Innoviva
5. North American Cannabis Holdings and Puration Prepare for Legal Marijuana Sector to Potentially Triple from $7 Billion to $22 Billion After Votes Today are Tabulated
6. Morphotek Announces Collaboration with Mayo Clinic to Apply Its Folate Receptor Alpha Diagnostic Assays in a Phase II Clinical Trial in Triple-Negative Breast Cancer
7. Data On Anti-Tumor Activity Of ENMD-2076 In Triple Negative Breast Cancer Animal Models Presented In Poster Session At AACR-NCI-EORTC International Conference
8. goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position
9. India Coronary Stent Market to be Tripled by 2021
10. TapImmune Appoints Patrick D. Yeramian, MD, Consulting Medical Director to Lead Phase II Clinical Trials in Triple Negative Breast and HER2/neu Breast Cancer
11. Top 10 Health Care Trends Report Finds Opportunities to Achieve "Triple Aim"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... MARLBOROUGH, Mass., May 10, 2017 Hologic, Inc. ... financial results for the fiscal second quarter ended April ... (EPS) of $1.84 increased 666.7% compared to the prior ... business resulted in a significant gain, while non-GAAP diluted ... increased 3.2%, or 3.8% in constant currency terms.  Excluding ...
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet ... in musculoskeletal healthcare, today announced it has earned a ... of 2017" list. The Company was ranked among 500 ... Large Employers and Healthcare Equipment and Services. ... based on an anonymous, independent survey of over 30,000 ...
(Date:5/8/2017)... Mich. , May 8, 2017  Diplomat Pharmacy, ... WRB Communications, Inc. ("WRB"), a health care service ... . WRB specializes in relationship management programs ... WRB will join ... Diplomat,s commercialization support services for manufacturers, biotech firms, and ...
Breaking Medicine Technology:
(Date:5/27/2017)... Syracuse, NY (PRWEB) , ... May 27, 2017 , ... ... EarQ and Oticon. The three-day event was held at the Marriott Syracuse Downtown ... events with the hearing brand and network of independent hearing healthcare providers to help ...
(Date:5/26/2017)... ... May 26, 2017 , ... Mediaplanet is proud to ... campaign in USA Today, which will educate readers on how to take care of ... a large focus is placed on melanoma. Dancing with the Stars professional, Witney Carson, ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... Boston CEO 2017 on May 30th and 31st at The Four Seasons Hotel ... leading executives in the life sciences, offering exclusive access to key decision makers ...
(Date:5/26/2017)... Texas (PRWEB) , ... May 26, 2017 , ... Amir ... Stimulation System, a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita SCS ... , “We are pleased to be the first in Arkansas to introduce the most ...
(Date:5/26/2017)... , ... May 26, 2017 , ... A new analysis ... with the healthiest seniors are located in the Midwest. With the average cost of ... more people are concerned with both the quality and affordability of where they live. ...
Breaking Medicine News(10 mins):